| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443447 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
Baseline NLR is a readily available and inexpensive prognostic biomarker in patients with BTC and likely warrants validation in large prospective clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M.G. McNamara, A.J. Templeton, M. Maganti, T. Walter, A.M. Horgan, L. McKeever, T. Min, E. Amir, J.J. Knox,